An approach to diagnosis and management of patients with pyoderma gangrenosum from an international perspective: results from an expert forum

Affiliations

¹ School of Medicine, Oregon Health and Science University, Portland, OR, USA.
² Department of Dermatology, Oregon Health and Science University, Portland, OR, 97239, USA. ortegalo@ohsu.edu.
³ Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
⁴ Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
⁵ Department of Dermatology, Mayo Clinic, Rochester, MN, USA.
⁶ Department of Dermatology, University of Pisa, Pisa, Italy.
⁷ Department of Dermatology, Venerology and Allergology, University of Essen, Essen, Germany.
⁸ Department of Dermatology, The Royal Victoria Infirmary, Newcastle Upon Tyne, UK.
⁹ Newcastle Biomedical Research Centre, Newcastle Upon Tyne, UK.
¹⁰ Department of Dermatology and Department of Biomedical Engineering, University Hospital of Basel, Basel, Switzerland.
¹¹ Dermatology Clinic, Wolfson Medical Center, Holon, Israel.
¹² The Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
¹³ Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.
¹⁴ Department of Dermatology, Fukushima Medical University, Fukushima, Japan.

Olivia M Haddadin et al. Arch Dermatol Res. 2024.

. 2024 Feb 24;316(3):89.

doi: 10.1007/s00403-024-02829-0.

¹ School of Medicine, Oregon Health and Science University, Portland, OR, USA.
² Department of Dermatology, Oregon Health and Science University, Portland, OR, 97239, USA. ortegalo@ohsu.edu.
³ Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
⁴ Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
⁵ Department of Dermatology, Mayo Clinic, Rochester, MN, USA.
⁶ Department of Dermatology, University of Pisa, Pisa, Italy.
⁷ Department of Dermatology, Venerology and Allergology, University of Essen, Essen, Germany.
⁸ Department of Dermatology, The Royal Victoria Infirmary, Newcastle Upon Tyne, UK.
⁹ Newcastle Biomedical Research Centre, Newcastle Upon Tyne, UK.
¹⁰ Department of Dermatology and Department of Biomedical Engineering, University Hospital of Basel, Basel, Switzerland.
¹¹ Dermatology Clinic, Wolfson Medical Center, Holon, Israel.
¹² The Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
¹³ Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.
¹⁴ Department of Dermatology, Fukushima Medical University, Fukushima, Japan.

No abstract available

Comment in

Analyzing global research trends and focal points of pyoderma gangrenosum from 1930 to 2023: visualization and bibliometric analysis.
Zyoud SH. Zyoud SH. J Transl Med. 2024 May 27;22(1):508. doi: 10.1186/s12967-024-05306-4. J Transl Med. 2024. PMID: 38802936 Free PMC article. No abstract available.

Analyzing global research trends and focal points of pyoderma gangrenosum from 1930 to 2023: visualization and bibliometric analysis.
Zyoud SH. Zyoud SH. J Transl Med. 2024 May 27;22(1):508. doi: 10.1186/s12967-024-05306-4. J Transl Med. 2024. PMID: 38802936 Free PMC article. No abstract available.
Clinical Mimickers Misdiagnosed as Pyoderma Gangrenosum.
Becker SL, Badawi AH, Thornton C, Ortega-Loayza AG. Becker SL, et al. Am J Clin Dermatol. 2025 Jul;26(4):511-523. doi: 10.1007/s40257-025-00941-z. Epub 2025 Mar 28. Am J Clin Dermatol. 2025. PMID: 40155526 Review.
Pyoderma Gangrenosum: A Nightmare for Breast Surgery-Two Case Reports.
Akoğlu G, Demiriz M, Yılmaz KB. Akoğlu G, et al. Eur J Breast Health. 2025 Jan 1;21(1):80-84. doi: 10.4274/ejbh.galenos.2024.2024-7-5. Eur J Breast Health. 2025. PMID: 39744929 Free PMC article.

1. Afifi L, Ortega-Loayza AG, Shinkai K (2020) Management of classic ulcerative pyoderma gangrenosum. Cutis 106(3):119–123. https://doi.org/10.12788/cutis.0076 - DOI - PubMed
1. Alavi A, French LE, Davis MD, Brassard A, Kirsner RS (2017) Pyoderma gangrenosum: an update on pathophysiology, diagnosis and treatment. Am J Clin Dermatol 18(3):355–372. https://doi.org/10.1007/s40257-017-0251-7 - DOI - PubMed
1. Dissemond J, Marzano AV, Hampton PJ, Ortega-Loayza AG (2023) Pyoderma gangrenosum: treatment options. Drugs 83(14):1255–1267. https://doi.org/10.1007/s40265-023-01931-3 - DOI - PubMed - PMC
1. Maverakis E, Le ST, Callen J, Wollina U, Marzano AV, Wallach D, Schadt C, Martinez-Alvarado YC, Cheng MY, Ma C, Merleev A, Ormerod A, Craig F, Jockenhöfer F, Dissemond J, Salva K, Williams HC, Fiorentino D (2019) New validated diagnostic criteria for pyoderma gangrenosum. J Am Acad Dermatol 80(4):87–88. https://doi.org/10.1016/j.jaad.2018.08.068 - DOI
1. Pimentel MA, Li MM, Noe MH, Latour E, Seminario-Vidal L, Greiling T, Shinkai K, Hamilton A, Alavi A, Bolognia JL, Cowen EW, Dominguez A, Fernandez AP, Fivenson D, Huang WW, Madigan LM, Mauskar M, Means AD, Nelson CA, Patsatsi A, Ortega-Loayza AG (2023) Features that define clinical severity of ulcerative pyoderma gangrenosum: a Delphi consensus study of experts and patients on behalf of the US medical dermatology society. Br J Dermatol 188(4):566–568. https://doi.org/10.1093/bjd/ljac137 - DOI - PubMed